According to a report in news agency ANI, Balkrishna said that a trial was conducted on hundreds of Covid-19 patients and that the medicine has yielded “100% favourable results.”

Swami Ram Dev and Acharya Balkrishna with Patanjali product.
As researchers across the globe race to develop a vaccine to tackle the pandemic, Acharya Balkrishna, co-founder and Chief Executive Officer (CEO) of Patanjali Ayurveda Limited, claimed that his company developed an Ayurveda medicine that has cured Covid-19 patients within a span of five to 14 days.
According to a report in news agency ANI, Balkrishna on Saturday said that a trial was conducted on hundreds of Covid-19 patients and that the medicine has yielded “100% favourable results”. However, there has been no statement regarding the claim by the Health Ministry or ICMR so far.

“We appointed a team of scientists after the Covid-19 outbreak. First, the simulation was done and compounds were identified which can fight the virus and stop its spread in the body. Then, we conducted a clinical case study on hundreds of positive patients and we have got 100 per cent favourable results,” Balkrishna said in Haridwar, according to ANI.

Noida International Airport gets Akasa Air flights to Navi Mumbai and Bengaluru

NEET-UG re-exam to see unprecedented security measures, says NTA chief

India, France deepen strategic partnership with focus on innovation and technology

IIM Ranchi partners with Masai to introduce product management executive program

ISRO launches Junior Research Fellowship program, applications open until July 11

Noida International Airport gets Akasa Air flights to Navi Mumbai and Bengaluru

IIM Ranchi partners with Masai to introduce product management executive program

Doctor's prescription now mandatory for all cough syrup purchases
.jpg&w=256&q=75)
Mumbai still awaits monsoon as India grapples with a 64% rainfall deficit

NEET UG 2026 re-exam: Telegram restrictions imposed to curb fake paper leak claims

Noida International Airport gets Akasa Air flights to Navi Mumbai and Bengaluru

NEET-UG re-exam to see unprecedented security measures, says NTA chief

India, France deepen strategic partnership with focus on innovation and technology

IIM Ranchi partners with Masai to introduce product management executive program

ISRO launches Junior Research Fellowship program, applications open until July 11

Noida International Airport gets Akasa Air flights to Navi Mumbai and Bengaluru

IIM Ranchi partners with Masai to introduce product management executive program

Doctor's prescription now mandatory for all cough syrup purchases
.jpg&w=256&q=75)
Mumbai still awaits monsoon as India grapples with a 64% rainfall deficit

NEET UG 2026 re-exam: Telegram restrictions imposed to curb fake paper leak claims
Copyright© educationpost.in 2024 All Rights Reserved.
Designed and Developed by @Pyndertech